Close

Kuopio university hospital in Finland adopts Zoll autopulse non-invasive cardiac support pump

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

UK Life Sciences Sector Plan Eases Startup Regulations

How the UK Life Sciences Sector Plan Reduces Regulatory...

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, announced today that the Kuopio University Hospital (KUH), one of the largest hospitals in Finland, has successfully implemented the AutoPulse® Non-invasive Cardiac Support Pump in its Intensive Care department. KUH is the first hospital in Finland to establish protocols for using the AutoPulse.

Jouni O. Kurola, M.D., Department of Anesthesiology and Intensive Care, KUH, recommended the implementation following a successful evaluation of an AutoPulse provided to the hospital by ZOLL. “It is remarkable to see how fast our nursing staff adopted the AutoPulse system in our Intensive Care unit,” he said. The AutoPulse gives us the opportunity to provide the best possible care for Sudden Cardiac Arrest (SCA) victims. Our colleagues in Interventional Cardiology have learned from our successes and now use the device as well.”

AutoPulse is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes a wider area of the chest in a consistent, uninterrupted “hands-free” manner, improving blood flow to the heart and brain during cardiac arrest.

Richard A. Packer, Chairman and Chief Executive Officer of ZOLL said, We’re pleased that Kuopio University hospital, one of the largest and most respected in Finland, has recognized the potential the AutoPulse® has to provide care for SCA victims in their Intensive Care department and Cath Lab by delivering consistent, high-quality chest compressions. AutoPulse moves more blood more effectively than manual compressions, thereby providing the best possible patient care.

Latest stories

Related stories

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

UK Life Sciences Sector Plan Eases Startup Regulations

How the UK Life Sciences Sector Plan Reduces Regulatory...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back